Scott Blumberg serves as Chief Financial Officer at Ceribell Inc., a medical technology company transforming critical care neurology with its innovative point-of-care EEG system, Ceribell System. With more than 25 years of experience in finance, accounting, and operations within the healthcare and medical device sectors, Scott oversees all financial aspects of the company, including strategic planning, capital raises, investor relations, and operational scaling. His leadership ensures Ceribell’s financial health as it expands its commercial presence and advances its mission to detect neurological conditions like seizures earlier and more effectively. Prior to Ceribell, Scott was CFO at NeuroPace, Inc., where he guided the neurostimulation company through its successful 2014 initial public offering on NASDAQ, raising over $70 million, and navigated subsequent growth amid revenue expansion and product launches. He previously held senior finance roles at Integra LifeSciences as Vice President of Finance for Global Orthopedics, and at Stryker Corporation as Director of Finance for the Spine division. Scott began his career at Deloitte & Touche, honing his expertise in audit and advisory services for healthcare clients. A Certified Public Accountant, Scott earned a Bachelor of Science in Accounting from the University of Delaware. His track record of driving financial discipline, funding successes, and operational efficiency in high-growth medtech environments has positioned Ceribell for sustained innovation and market leadership in brain health monitoring.